avapro has been researched along with Nephrotic Syndrome in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment." | 5.39 | Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013) |
| "A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment." | 1.39 | Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurasawa, T | 1 |
| Nagasawa, H | 1 |
| Nishi, E | 1 |
| Takei, H | 1 |
| Okuyama, A | 1 |
| Kondo, T | 1 |
| Nishimura, K | 1 |
| Sakai, R | 1 |
| Shibata, A | 1 |
| Chino, K | 1 |
| Ogawa, H | 1 |
| Ito, T | 1 |
| Amano, K | 1 |
| Kato, H | 1 |
| Wang, YC | 1 |
| Chuang, FR | 1 |
| Lee, WC | 1 |
| Chen, TC | 1 |
| Ko, SF | 1 |
| Wang, IK | 1 |
| Lee, CH | 1 |
| Simonetti, GD | 1 |
| Bianchetti, MG | 1 |
| Konrad, M | 1 |
| von Vigier, RO | 1 |
| Zhou, A | 1 |
| Yu, L | 1 |
| Li, J | 1 |
| Zhang, J | 1 |
| Wang, H | 1 |
4 other studies available for avapro and Nephrotic Syndrome
| Article | Year |
|---|---|
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therap | 2013 |
Low-molecular-weight heparin successfully used to treat a nephrotic patient complicated by superior mesenteric vein thrombosis and portal vein thrombosis.
Topics: Antihypertensive Agents; Biphenyl Compounds; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; | 2011 |
Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
Topics: Anemia; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Child; Erythropoietin; Hemoglob | 2007 |
Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compou | 2000 |